Welcome to the Department of Oncology
The Norwegian Radium Hospital (NRH) is constantly carrying out intensive research on new cancer treatment methods. The development of new treatments are initially taking place in laboratories by experimenting on isolated cells, tissue and in animal models. Drugs showing promising activities in the model systems are then tested out thoroughly in clinical studies on patients with cancer. A large number of the patients at the NRH are participating in various clinical studies.
Cancer treatment programmes
The hospital activity is organized according to Treatment Programmes. Each treatment program organize their own research activity.
| Cancer treatment programme: |
Head of programme |
| Breast cancer | Bjørn Naume |
| Gynaecological cancer (choriocarcinoma, cervical cancer, ovarial cancer, vulva cancer) Affilitated with: Woman and children's Division |
Claes G. Trope |
| Head & neck cancer | Jan F. Evensen |
| Lung cancer | Johny Kongerud, Paal Brunsvig |
| Lymphoma | Harald Holte |
| Sarcoma | Kirsten Sundby Hall |
| CNS tumors and eye cancer | Knut Lote |
| Colorectal, upper GI and anal cancer | Svein Dueland |
| Malignant melanomas, skin tumores |
Steinar Aamdal |
| Testicular, bladder/penis and prostate cancer | Karl Axcrona, Gustav Lehne |
| Thyoroidal cancer | Trine Bjøro |
Clinical research on new therapies and procedures in human beings is often time consuming and difficult to carry out at an ordinary hospital ward. The Norwegian Radium Hospital therefore established its Clinical Cancer Research Unit with its own doctors and specially trained nurses for early drug development (phase I and II studies).
Aug 31, 2010
Oslo, September 20-22, 2010
Aug 30, 2010
Latest publications
Department of Oncology
Expression levels of uridine 5'-diphospho-glucuronosyltransferase genes in breast tissue from healthy women are associated with mammographic density
Breast Cancer Res, 12 (4), R65 (in press)
PubMed 20799965
Excessive Soft Tissue Reaction after Stereotactic Body Radiation Therapy in a Woman with Four Different Cancer Diagnoses
Case Rep Oncol, 3 (2), 195-201
PubMed 20740196
Distinct choline metabolic profiles are associated with differences in gene expression for basal-like and luminal-like breast cancer xenograft models
BMC Cancer, 10 (1), 433
PubMed 20716336





Print this page
